表紙
市場調查報告書

eClinical (臨床試驗電子化) 解決方案的全球市場:產業趨勢、預測

Global eClinical Solutions Market: Industry Trends and Forecast to 2026

出版商 Data Bridge Market Research Private Limited 商品編碼 915554
出版日期 內容資訊 英文 203 Pages
商品交期: 最快1-2個工作天內
價格
eClinical (臨床試驗電子化) 解決方案的全球市場:產業趨勢、預測 Global eClinical Solutions Market: Industry Trends and Forecast to 2026
出版日期: 2019年10月01日內容資訊: 英文 203 Pages
簡介

本報告提供全球eClinical (臨床試驗電子化) 解決方案市場調查分析,市場概要,市場趨勢,各市場區隔的市場分析,各地區預測,主要企業等相關的系統性資訊。

第1章 簡介

第2章 市場區隔

第3章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第4章 摘要整理

第5章 重要考察

第6章 全球eClinical (臨床試驗電子化) 解決方案市場:各產品

  • 概要
  • 電子資料收集 (EDC)、臨床資料管理系統 (CDMS)
  • 非人為化、臨床實驗藥供給管理 (RTSM)
  • 臨床實驗管理系統 (CTMS)
  • 電子臨床結果評估 (eCOA)
  • 電子臨床實驗主文件 (eTMF) 系統
  • 安全性解決方案
  • 法規資訊管理解決方案
  • 臨床資料整合平台
  • 臨床分析平台
  • 其他

第7章 全球eClinical (臨床試驗電子化) 解決方案市場:各部署類型

  • 概要
  • Web託管 (按需) 解決方案
  • 雲端基礎 (SaaS) 解決方案
  • 許可證企業 (內部部署)解決方案

第8章 全球eClinical (臨床試驗電子化) 解決方案市場:各臨床實驗階段

  • 概要
  • 階段III
  • 階段II
  • 階段IV
  • 階段I

第9章 全球eClinical (臨床試驗電子化) 解決方案市場:各終端用戶

  • 概要
  • 醫院/醫療機關
  • CRO
  • 學術機構
  • 製藥、生物科技企業
  • 醫療設備廠商
  • 諮詢服務企業

第10章 全球eClinical (臨床試驗電子化) 解決方案市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第11章 全球eClinical (臨床試驗電子化) 解決方案市場:企業形勢

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第12章 企業簡介

  • ORACLE
  • MEDIDATA SOLUTIONS
  • PAREXEL INTERNATIONAL CORPORATION
  • BIOCLINICA
  • ERT CLINICAL
  • ARIS GLOBAL
  • ADVARRA
  • ANJU SOFTWARE
  • BIO-OPTRONICS, INC
  • DATATRAK INT.
  • ECLINICALWORKS
  • ECLINICAL SOLUTIONS LLC
  • IBM CORPORATION
  • ICON PLC
  • MASTERCONTROL, INC.
  • MAXISIT
  • OMNICOMM SYSTEMS, INC
  • RESONANCE HEALTH
  • REALTIME
  • SIGNANT HEALTH
  • VEEVA SYSTEMS
  • XYBION CORPORATION

第13章 問卷調查

第14章 相關調查

目錄

Global eClinical solutions market is projected to register a healthy CAGR of 13.4% in the forecast period of 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Product {Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Randomization and Trial Supply Management (RTSM), Clinical Trial Management Systems (CTMS), Electronic Clinical Outcome Assessment (ECOA), Electronic Trial Master File Systems, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms, Other eClinical Solutions}, Deployment {Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions, Licensed Enterprise (On-Premise) Solutions}, Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), End User {Hospital/Healthcare Provider, Contract Research Organizations (CROS), Pharma & Biotech Organizations, Medical Device Manufacturers, Consulting Service Companies, Academic Institutes}, Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Some of the major factors contributing to the growth of the market:

  • Increasing adoption of clinical trials
  • Increasing life sciences R&D expenditure
  • Rising government initiatives

Market Players:

The key market players for global eClinical solutions market are listed below:

  • Parexel International Corporation
  • Oracle
  • Medidata Solutions, Inc.
  • Veeva Systems
  • ERT Clinical
  • eClinical Solutions LLC
  • IBM Corporation
  • eClinicalWorks
  • Bioclinica
  • ArisGlobal
  • Advarra
  • Anju Software, Inc.
  • Bio-Optronics, Inc.
  • DATATRAK Int.
  • ICON plc
  • MasterControl, Inc.
  • MaxisIT
  • OmniComm Systems, Inc.
  • RESONANCE HEALTH
  • The Realtime Group
  • Signant Health
  • Xybion Corporation
  • Others

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL ECLINICAL SOLUTIONS MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GLOBAL ECLINICAL SOLUTIONS MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 MULTIVARIATE MODELING
  • 2.9 PRODUCTS LIFELINE CURVE
  • 2.10 SECONDARY SOURCES
  • 2.11 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 INCREASING ADOPTION OF CLINICAL TRIALS
    • 3.1.2 RISING GOVERNMENT INITIATIVES
    • 3.1.3 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION
    • 3.1.4 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 3.2 RESTRAINTS
    • 3.2.1 DEARTH OF TRAINED PROFESSIONALS
    • 3.2.2 HIGH IMPLEMENTATION COST
  • 3.3 OPPORTUNITIES
    • 3.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
    • 3.3.2 TECHNOLOGICAL ADVANCEMENT
  • 3.4 CHALLENGES
    • 3.4.1 STRINGENT REGULATIONS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT

  • 6.1 OVERVIEW
  • 6.2 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS)
  • 6.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM)
  • 6.4 CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS)
  • 6.5 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA)
  • 6.6 ELECTRONIC TRIAL MASTER FILE SYSTEM
  • 6.7 SAFETY SOLUTIONS
  • 6.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
  • 6.9 CLINICAL DATA INTEGRATION PLATFORMS
  • 6.10 CLINICAL ANALYTICS PLATFORMS
  • 6.11 OTHER ECLINICAL SOLUTIONS

7 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE

  • 7.1 OVERVIEW
  • 7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
  • 7.3 CLOUD-BASED (SAAS) SOLUTIONS
  • 7.4 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS

8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE

  • 8.1 OVERVIEW
  • 8.2 PHASE III
  • 8.3 PHASE II
  • 8.4 PHASE IV
  • 8.5 PHASE I

9 GLOBAL ECLINICAL SOLUTIONSMARKET, BY END USER

  • 9.1 OVERVIEW
  • 9.2 HOSPITALS/HEALTHCARE PROVIDERS
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
  • 9.4 ACADEMIC INSTITUTES
  • 9.5 PHARMA & BIOTECH ORGANIZATIONS
  • 9.6 MEDICAL DEVICE MANUFACTURERS
  • 9.7 CONSULTING SERVICE COMPANIES

10 GLOBAL ECLINICAL SOLUTIONS MARKET, BY GEOGRAPHY

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 U.S.
    • 10.2.2 CANADA
    • 10.2.3 MEXICO
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 U.K.
    • 10.3.3 ITALY
    • 10.3.4 FRANCE
    • 10.3.5 RUSSIA
    • 10.3.6 SWITZERLAND
    • 10.3.7 NETHERLANDS
    • 10.3.8 SPAIN
    • 10.3.9 TURKEY
    • 10.3.10 BELGIUM
    • 10.3.11 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 JAPAN
    • 10.4.2 CHINA
    • 10.4.3 INDIA
    • 10.4.4 SOUTH KOREA
    • 10.4.5 AUSTRALIA
    • 10.4.6 SINGAPORE
    • 10.4.7 THAILAND
    • 10.4.8 MALAYSIA
    • 10.4.9 INDONESIA
    • 10.4.10 PHILIPPINES
    • 10.4.11 REST OF ASIA-PACIFIC
  • 10.5 SOUTH AMERICA
    • 10.5.1 BRAZIL
    • 10.5.2 REST OF SOUTH AMERICA
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 SOUTH AFRICA
    • 10.6.2 REST OF MIDDLE EAST AND AFRICA

11 GLOBAL ECLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE

  • 11.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 11.3 COMPANY SHARE ANALYSIS: EUROPE
  • 11.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC

12 COMPANY PROFILE

  • 12.1 ORACLE
    • 12.1.1 COMPANY SNAPSHOT
    • 12.1.2 REVENUE ANALYSIS
    • 12.1.3 COMPANY SHARE ANALYSIS
    • 12.1.4 PRODUCT PORTFOLIO
    • 12.1.5 RECENT DEVELOPMENTS
  • 12.2 MEDIDATA SOLUTIONS
    • 12.2.1 COMPANY SNAPSHOT
    • 12.2.2 REVENUE ANALYSIS
    • 12.2.3 COMPANY SHARE ANALYSIS
    • 12.2.4 PRODUCT PORTFOLIO
    • 12.2.5 RECENT DEVELOPMENT
  • 12.3 PAREXEL INTERNATIONAL CORPORATION
    • 12.3.1 COMPANY SNAPSHOT
    • 12.3.2 COMPANY SHARE ANALYSIS
    • 12.3.3 PRODUCT PORTFOLIO
    • 12.3.4 RECENT DEVELOPMENTS
  • 12.4 BIOCLINICA
    • 12.4.1 COMPANY SNAPSHOT
    • 12.4.2 PRODUCT PORTFOLIO
    • 12.4.3 RECENT DEVELOPMENTS
  • 12.5 ERT CLINICAL
    • 12.5.1 COMPANY SNAPSHOT
    • 12.5.2 PRODUCT PORTFOLIO
    • 12.5.3 RECENT DEVELOPMENTS
  • 12.6 ARIS GLOBAL
    • 12.6.1 COMPANY SNAPSHOT
    • 12.6.2 PRODUCT PORTFOLIO
    • 12.6.3 RECENT DEVELOPMENTS
  • 12.7 ADVARRA
    • 12.7.1 COMPANY SNAPSHOT
    • 12.7.2 PRODUCT PORTFOLIO
    • 12.7.3 RECENT DEVELOPMENTS
  • 12.8 ANJU SOFTWARE
    • 12.8.1 COMPANY SNAPSHOT
    • 12.8.2 PRODUCT PORTFOLIO
    • 12.8.3 RECENT DEVELOPMENTS
  • 12.9 BIO-OPTRONICS, INC
    • 12.9.1 COMPANY SNAPSHOT
    • 12.9.2 PRODUCT PORTFOLIO
    • 12.9.3 RECENT DEVELOPMENTS
  • 12.10 DATATRAK INT.
    • 12.10.1 COMPANY SNAPSHOT
    • 12.10.2 REVENUE ANALYSIS
    • 12.10.3 SOLUTION PORTFOLIO
    • 12.10.4 RECENT DEVELOPMENTS
  • 12.11 ECLINICALWORKS
    • 12.11.1 COMPANY SNAPSHOT
    • 12.11.2 PRODUCT PORTFOLIO
    • 12.11.3 RECENT DEVELOPMENTS
  • 12.12 ECLINICAL SOLUTIONS LLC
    • 12.12.1 COMPANY SNAPSHOT
    • 12.12.2 PRODUCT PORTFOLIO
    • 12.12.3 RECENT DEVELOPMENTS
  • 12.13 IBM CORPORATION
    • 12.13.1 COMPANY SNAPSHOT
    • 12.13.2 REVENUE ANALYSIS
    • 12.13.3 PRODUCT PORTFOLIO
    • 12.13.4 RECENT DEVELOPMENT
  • 12.14 ICON PLC
    • 12.14.1 COMPANY SNAPSHOT
    • 12.14.2 REVENUE ANALYSIS
    • 12.14.3 SERVICE PORTFOLIO
    • 12.14.4 RECENT DEVELOPMENTS
  • 12.15 MASTERCONTROL, INC.
    • 12.15.1 COMPANY SNAPSHOT
    • 12.15.2 SOLUTION PORTFOLIO
    • 12.15.3 RECENT DEVELOPMENTS
  • 12.16 MAXISIT
    • 12.16.1 COMPANY SNAPSHOT
    • 12.16.2 PRODUCT PORTFOLIO
    • 12.16.3 RECENT DEVELOPMENT

  • 12.17 OMNICOMM SYSTEMS, INC
    • 12.17.1 COMPANY SNAPSHOT
    • 12.17.2 REVENUE ANALYSIS
    • 12.17.3 PRODUCT PORTFOLIO
    • 12.17.4 RECENT DEVELOPMENTS
  • 12.18 RESONANCE HEALTH
    • 12.18.1 COMPANY SNAPSHOT
    • 12.18.2 REVENUE ANALYSIS
    • 12.18.3 PRODUCT PORTFOLIO
    • 12.18.4 RECENT DEVELOPMENTS
  • 12.19 REALTIME
    • 12.19.1 COMPANY SNAPSHOT
    • 12.19.2 PRODUCT PORTFOLIO
    • 12.19.3 RECENT DEVELOPMENT
  • 12.20 SIGNANT HEALTH
    • 12.20.1 COMPANY SNAPSHOT
    • 12.20.2 SOLUTION PORTFOLIO
    • 12.20.3 RECENT DEVELOPMENTS
  • 12.21 VEEVA SYSTEMS
    • 12.21.1 COMPANY SNAPSHOT
    • 12.21.2 REVENUE ANALYSIS
    • 12.21.3 COMPANY SHARE ANALYSIS
    • 12.21.4 PRODUCT PORTFOLIO
    • 12.21.5 RECENT DEVELOPMENT
  • 12.22 XYBION CORPORATION
    • 12.22.1 COMPANY SNAPSHOT
    • 12.22.2 PRODUCT PORTFOLIO
    • 12.22.3 RECENT DEVELOPMENTS

13 QUESTIONNAIRE

14 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS
  • TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
  • TABLE 3 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 4 GLOBAL ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 5 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 GLOBAL ELECTRICAL TRIAL MASTER FILE SYSTEM IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 GLOBAL SAFETY SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 11 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 GLOBAL CLINICAL ANALYTICS PLATFORMS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 13 GLOBAL OTHER ECLINICAL SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 14 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 15 GLOBAL WEB-HOSTED (ON-DEMAND) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 GLOBAL CLOUD-BASED (SAAS) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 17 GLOBAL LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 19 GLOBAL PHASE III IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 GLOBAL PHASE II IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 GLOBAL PHASE IV IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 22 GLOBAL PHASE I IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 24 GLOBAL HOSPITALS/HEALTHCARE PROVIDERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25 GLOBAL CONTRACT RESEARCH ORGANIZATIONS (CROS) IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 GLOBAL ACADEMIC INSTITUTES COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 27 GLOBAL PHARMA & BIOTECH ORGANIZATIONS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 GLOBAL MEDICAL DEVICE MANUFACTURERS IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 GLOBAL CONSULTING SERVICE COMPANIES IN ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 30 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 33 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 34 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 35 NORTH AMERICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 36 U.S. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 37 U.S. ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 38 U.S. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 39 U.S. ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 40 CANADA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 41 CANADA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 42 CANADA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 43 CANADA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 44 MEXICO ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 45 MEXICO ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 46 MEXICO ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 47 MEXICO ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 48 EUROPE ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 49 EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 50 EUROPE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 51 EUROPE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 52 EUROPE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 53 GERMANY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 54 GERMANY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 55 GERMANY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 56 GERMANY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 57 U.K. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 58 U.K. ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 59 U.K. ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 60 U.K. ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 61 ITALY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 62 ITALY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 63 ITALY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 64 ITALY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 65 FRANCE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 66 FRANCE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 67 FRANCE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 68 FRANCE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 69 RUSSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 70 RUSSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 71 RUSSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 72 RUSSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 73 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 74 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 75 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 76 SWITZERLAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 77 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 78 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 79 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 80 NETHERLANDS ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 81 SPAIN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 82 SPAIN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 83 SPAIN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 84 SPAIN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 85 TURKEY ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 86 TURKEY ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 87 TURKEY ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 88 TURKEY ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 89 BELGIUM ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 90 BELGIUM ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 91 BELGIUM ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 92 BELGIUM ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 93 REST OF EUROPE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 94 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 95 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 96 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 97 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 98 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 99 JAPAN ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 100 JAPAN ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 101 JAPAN ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 102 JAPAN ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 103 CHINA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 104 CHINA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 105 CHINA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 106 CHINA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 107 INDIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 108 INDIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 109 INDIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 110 INDIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 111 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 112 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 113 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 114 SOUTH KOREA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 115 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 116 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 117 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 118 AUSTRALIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 119 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 120 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 121 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 122 SINGAPORE ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 123 THIALAND ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 124 THIALAND ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 125 THIALAND ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 126 THIALAND ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 127 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 128 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 129 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 130 MALAYSIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 131 INDONESIA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 132 INDONESIA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 133 INDONESIA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 134 INDONESIA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 135 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 136 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 137 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 138 PHILIPPINES ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 139 REST OF ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 140 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 141 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 142 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 143 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 144 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 145 BRAZIL ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 146 BRAZIL ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 147 BRAZL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 148 BRAZIL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 149 REST OF SOUTH AMERICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 150 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 151 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 152 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 153 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 154 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 155 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)
  • TABLE 156 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY DEPLOYMENT TYPE, 2017-2026 (USD MILLION)
  • TABLE 157 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017-2026 (USD MILLION)
  • TABLE 158 SOUTH AFRICA ECLINICAL SOLUTIONS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 159 REST OF MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 GLOBAL ECLINICAL SOLUTIONS MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL ECLINICAL SOLUTIONS MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL ECLINICAL SOLUTIONS MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL ECLINICAL SOLUTIONS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL ECLINICAL SOLUTIONS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL ECLINICAL SOLUTIONS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL ECLINICAL SOLUTIONS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF THE GLOBAL ECLINICAL SOLUTIONS MARKET
  • FIGURE 9 CLINICAL TRIAL CONDUCTED PER YEAR
  • FIGURE 10 THE MARKET GROWTH IN CLINICAL CRO (IN USD MILLIONS)
  • FIGURE 11 THE FUNCTION OF CRO
  • FIGURE 12 WORLDWIDE BIOPHARMA COMPANIES R&D EXPENDITURE (IN MILLION U.S. DOLLARS)
  • FIGURE 13 ECLINICAL ENTERPRISE PRICING PACKAGES
  • FIGURE 14 COMPARISON OF TECHNOLOGIES USED BY CROS IN CLINICAL RESEARCH PROCESS
  • FIGURE 15 GLOBAL ECLINICAL SOLUTIONS MARKET: SEGMENTATION
  • FIGURE 16 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATION AND RISING GOVERNMENT INITITAIVES ARE EXPECTED TO DRIVE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 17 ELECTRONIC DATA CAPTURE (EDC) AND CLINICAL DATA MANAGEMENT SYSTEMS (CDMS) IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2019
  • FIGURE 18 ASIA-PACIFIC IS THE MAXIMUM GROWING AND NORTH AMERICA IS THE MOST PROFITABLE REVENUE POCKETS FOR GLOBAL ECLINICAL SOLUTIONS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 19 GLOBAL ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2018)
  • FIGURE 20 GLOBAL ECLINICAL SOLUTIONS MARKET: BY DEPLOYMENT TYPE (2018)
  • FIGURE 21 GLOBAL ECLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE (2018)
  • FIGURE 22 GLOBAL ECLINICAL SOLUTIONS MARKET: BY END USER (2018)
  • FIGURE 23 GLOBAL ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018)
  • FIGURE 24 GLOBAL ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018)
  • FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 26 GLOBAL ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 27 GLOBAL ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026)
  • FIGURE 28 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018)
  • FIGURE 29 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018)
  • FIGURE 30 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 31 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 32 NORTH AMERICA ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026)
  • FIGURE 33 EUROPE ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018)
  • FIGURE 34 EUROPE ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018)
  • FIGURE 35 EUROPE ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 36 EUROPE ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 37 EUROPE ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026)
  • FIGURE 38 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018)
  • FIGURE 39 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018)
  • FIGURE 40 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 41 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 42 ASIA-PACIFIC ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026)
  • FIGURE 43 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018)
  • FIGURE 44 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018)
  • FIGURE 45 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 46 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 47 SOUTH AMERICA ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026)
  • FIGURE 48 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: SNAPSHOT (2018)
  • FIGURE 49 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018)
  • FIGURE 50 MIDDLE EAST AND AFRICA SOLUTIONS MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 51 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 52 MIDDLE EAST AND AFRICA ECLINICAL SOLUTIONS MARKET: BY PRODUCT (2019-2026)
  • FIGURE 53 GLOBAL ECLINICAL SOLUTIONS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 54 NORTH AMERICA INFLATION DEVICE MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 55 EUROPE INFLATION DEVICE MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 56 ASIA PACIFIC INFLATION DEVICE MARKET: COMPANY SHARE 2018 (%)